Optimizing Dry Mouth Treatment for Individuals with Sjögren's Syndrome

Rheumatic Disease Clinics of North America

Volumn 34, Issue 4, 2008, Pages 1001-1010

  Wu, Ava J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Artificial saliva; Remineralization; Salivary dysfunction; Sj gren's syndrome; Xerostomia

Indexed keywords

'VIADENT'; BETHANACHOL; CALCIUM; CAVITY SHIELD; CEVIMELINE; CHLORHEXIDINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CONTROL RX MULTI; DURAFLUOR; FLUOR PROTECTOR; FLUORIDE SODIUM; FLUORIDE VARNISH; FUORIGUARD; LINSEED OIL; MYCOLOG; NYSTATIN; PHOSPHATE; PILOCARPINE; PREVIDENT; PRIMROSE OIL; SALIVA SUBSTITUTE; SALIVE; SPRY; THERAGUM; TOOTHPASTE; UNCLASSIFIED DRUG; XYLICHEW; XYLITOL;

CLINICAL ASSESSMENT; DEMINERALIZATION; DENTAL CARIES; DRUG DOSE TITRATION; DRY EYE; FOOD INTAKE; HUMAN; INFECTION PREVENTION; MINIMALLY INVASIVE SURGERY; MOUTH CAVITY; MOUTH HYGIENE; MOUTH INFECTION; MOUTH MUCOSA; MOUTHWASH; MYCOSIS; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SALIVA ANALYSIS; SALIVARY GLAND; SALIVARY GLAND DISEASE; SALIVARY GLAND FUNCTION; SALIVATION; SIDE EFFECT; SJOEGREN SYNDROME; SWEATING; XEROSTOMIA;

DENTAL CARIES; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; SALIVA, ARTIFICIAL; SALIVARY GLANDS; SJOGREN'S SYNDROME; TOOTH REMINERALIZATION; XEROSTOMIA;

EID: 54549110069     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2008.08.013     Document Type: Review

References (36)

1. Atkinson J.C., Travis W.D., Pillemer S.R., et al. Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features. J Rheumatol 17 3 (1990) 318-322
2. Featherstone J.D. Prevention and reversal of dental caries: role of low-level fluoride. Community Dent Oral Epidemiol 27 1 (1999) 31-40
3. Featherstone J.D. The science and practice of caries prevention. J Am Dent Assoc 131 7 (2000) 887-899
4. Dawes C. Physiologic factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 66 Spec Iss (1987) 648-653
5. Wolff M.S., and Kleinberg L. The effect of ammonium glycopyrrolate (Robinol)-induced xerostomia on oral mucosa wetness and flow of gingival crevicular fluid in humans. Arch Oral Biol 44 (1999) 97-102
6. Vitali C., Bombardieri S., Jonsson R., et al. European Study Group on Classification Criteria for Sjögren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 6 (2002) 554-558
7. Sreebny L.M., and Zhu W.X. The use of whole saliva in the differential diagnosis of Sjögren's syndrome. Adv Dent Res 10 1 (1996) 17-24
8. Aragona P., Bucolo C., Spinella R., et al. Systemic omega 6 fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci 46 12 (2005) 4474-4479
9. Oxholm P., Manthorpe R., Prauss J.U., et al. Patients with primary Sjögren's syndrome treated for two months with evening primrose oil. Scand J Rheumatol 15 2 (1986) 103-108
10. Andersson G., Johansson G., Attström R., et al. Comparison of the effect of the linseed extract Salinum and a methycellulose preparation on the symptoms of dry mouth. Gerodontology 12 1 (1995) 12-17
11. Johansson G., Andersson G., Edwardsson S., et al. Effects of mouth rinses with linseed extract Salinum without/with chlorhexidine on oral conditions in patients with Sjögren's syndrome. A double- blind crossover investigation. Gerodontology 18 2 (2001) 87-94
12. Dreizen S., Brown L.R., Daly T.E., et al. Prevention of xerostomia-related dental caries in irradiated cancer patients. J Dent Res 56 2 (1977) 99-104
13. Jensen L., Budenz A.W., Featherstone J.D., et al. Clinical protocols for caries management by risk assessment. J Calif Dent Assoc 35 10 (2007) 714-723
14. Featherstone J.D., Young D.A., Domejean-Orliaguet S., et al. Caries risk assessment in practice for age 6 through adult. J Calif Dent Assoc 35 10 (2007) 703-713
15. Wu A.J. The oral component of Sjögren's syndrome: pass the scalpel and check the water. Curr Rheumatol Rep 5 4 (2003) 304-310
16. Jensdottir T., Holbrook P., Nauntofte B., et al. Immediate erosive potential of cola drinks and orange juices. J Dent Res 85 3 (2006) 226-230
17. Hara A.T., and Zero D.T. Analysis of the erosive potential of calcium-containing acidic beverages. Eur J Oral Sci 116 1 (2008) 60-65
18. Spolsky V.W., Black B.P., Jensen L., et al. Products-old, new, and emerging. J Calif Dent Assoc 35 10 (2007) 724-737
19. Igarishi K., Lee I.K., and Schachtele C.F. Effect of chewing gum containing sodium bicarbonate on human interproximal plaque pH. J Dent Res 67 3 (1998) 531-535
20. Anderson L.A., and Orchardson R. The effect of chewing bicarbonate-containing gum on salivary flow rate and pH in humans. Arch Oral Biol 48 3 (2003) 201-204
21. Lynch H., and Milgrom P. Xylitol and dental caries: an overview for clinicians. J Calif Dent Assoc 31 3 (2003) 205-209
22. Ly K.A., Milgrom P., and Rothen M. Xylitol, sweeteners, and dental caries. Pediatr Dent 28 2 (2006) 154-163
23. Burt B.A., and Pai S. Sugar consumption and caries risk: a systematic review. J Dent Educ 65 10 (2001) 1018-1023
24. Burt B. The use of sorbitol- and xylitol-sweetened chewing gum in caries control. J Am Dent Assoc 137 4 (2006) 190-196
25. Kalk W.W., Vissink A., Spijkervert F.K., et al. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 60 12 (2001) 1110-1116
26. White J., and Eakle S. Rationale and treatment approach in minimally invasive dentistry. J Am Dent Assoc 131 (2000) 13S-19S
27. Christensen G. The advantages of minimally invasive dentistry. J Am Dent Assoc 136 11 (2005) 1563-1565
28. Murdoch-Kinch C., and McLean M. Minimally invasive dentistry. J Am Dent Assoc 134 1 (2003) 87-95
29. Takagi Y., Kimura Y., and Nakamura T. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome. Ann Rheum Dis 63 6 (2004) 749
30. Chainani-Wu N., Gorsky M., Mayer P., et al. Assessment of the use of sialogogues in the clinical management of patients with xerostomia. Spec Care Dentist 26 4 (2006) 168-174
31. Dawes C. How much saliva is enough for avoidance of xerostomia?. Caries Res 38 3 (2004) 236-240
32. Patton L.L., Siegel M.A., Benoliel R., et al. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl (2007) 1-13
33. Garcia-Hermoso D., Dromer F., Improvisi L., et al. Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidiasis refractory to treatment with fluconazole. Antimicrob Agents Chemother 39 3 (1995) 656-660
34. Barkvoll P., and Attramadal A. Effect of nystatin and chlorhexidine gluconate on C albicans. Oral Surg Oral Med Oral Pathol 67 3 (1989) 279-281
35. Stewart C.M., Berg K.M., Cha S., et al. Salivary dysfunction and quality of life in Sjögren's syndrome. J Am Dent Assoc 139 3 (2008) 291-299
36. Young D.A., Featherstone J.D.B., and Roth J.R. Caries management by risk assessment-a practitioner's guide. J Calif Dent Assoc 35 10 (2007) 679-680